Parameters related to lipid metabolism as markers of myelination in mouse brain.
about
Alzheimer's disease as homeostatic responses to age-related myelin breakdownBiochemical Monitoring of Spinal Cord Injury by FT-IR Spectroscopy--Effects of Therapeutic Alginate Implant in Rat ModelsInterleukin-6 (IL-6) receptor/IL-6 fusion protein (Hyper IL-6) effects on the neonatal mouse brain: possible role for IL-6 trans-signaling in brain development and functional neurobehavioral outcomesN-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's DiseaseDefective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.Age- and brain region-specific effects of dietary vitamin K on myelin sulfatidesMembrane plasmalogen composition and cellular cholesterol regulation: a structure activity study.Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults.Brain lipid analysis in mice with Rett syndromeMyelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosisAnimal models of periventricular leukomalacia.Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levelsAxon-glia synapses are highly vulnerable to white matter injury in the developing brainα7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin NeurotoxicityCholesterol: its regulation and role in central nervous system disorders.Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.Developmental profiles of lipogenic enzymes and their regulators in the neonatal mouse brainMutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression.Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling.Ceramide function in the brain: when a slight tilt is enough.Adapting brain metabolism to myelination and long-range signal transduction.Zebrafish as a model to investigate CNS myelination.Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons.Fatty acid synthase: a novel target for antiglioma therapy.Aspartoacylase supports oxidative energy metabolism during myelinationAlterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination.Effects of dietary sphingomyelin on central nervous system myelination in developing rats.Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.Does Sirt2 Regulate Cholesterol Biosynthesis During Oligodendroglial Differentiation In Vitro and In Vivo?Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin.A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis.
P2860
Q22251261-C96C6A9B-6738-4550-ACD7-01D96CE44B0CQ28550864-CC390A54-B753-468D-AA17-8020696E7B9DQ30445005-CD643174-346E-4DCD-9140-A08C1B904F36Q33271816-7C1902EA-E047-4A07-AE8A-39D07746740FQ33631144-CCB484E0-D5B6-406A-A56F-51D6F09F20D1Q33933163-A992CD06-6426-4D14-BB02-0D21214A32A2Q33937624-0996DB35-567D-4542-918F-AC4DC95A4F26Q33986680-E8F4D3DD-1DE6-4080-AAB9-03526BCF6CCBQ34560712-D8219C54-1E3B-4D4C-9611-387A07D6073BQ34580887-B10E1D3C-3356-42C2-BAA8-2F261332F082Q34855127-6411E6B3-F1CD-49E5-B000-D295E07A7A4AQ35126311-B0D868C1-761A-4655-9828-E0CC3967EC8AQ35134958-7FBE1CED-429A-49C2-9025-84BB5F091148Q35314176-8DFD97E0-9430-4AEF-9B0E-7E8C22B624FBQ35531951-1FE52D8B-0EFC-4837-A7A6-51C62833CFFBQ35749490-C2BF66FA-9C24-455B-B182-2793C2547E70Q36355194-104DC833-7E44-4C22-8260-D16BC009CC6FQ37110581-CBED0105-FB61-42F2-91D5-6C9D240F8123Q37352030-6B5D4A24-B4BF-4A02-A5B8-D6B6AC9ED71FQ37603790-CB3DF641-95E0-4026-9FF2-A14D57000BA3Q37700656-F1705451-4E43-47DA-98DC-60C59712E171Q38021345-973A8435-B8DD-4818-B676-FA51F71A4BEAQ38240551-42636BBB-0C6B-4C0A-AD12-8339FB479F99Q38255026-2EC6ADA7-BC7A-44CE-A647-7F84B6F16B6BQ39367072-69306999-7CA0-46BC-8677-2D0CB3313375Q40232827-08542219-459E-4826-8062-25AD35A747CFQ42158100-B2D82F0E-258E-4C3E-90EE-997E9F5ECF09Q44046067-F518338A-4715-4980-8B4B-E1465B9B3231Q44337046-67C26569-117E-4DCD-B0AE-80B85DB6426FQ45248629-341F35C9-CB86-45C0-A311-CE2CE603B03EQ45410300-04795811-A2D6-4211-86ED-FD5BACF3D39CQ47923241-73FFECA4-A7A1-40C6-AEAD-714BC0580F41Q48323469-722205D5-6BFA-4958-831B-D51670990196Q49169217-392B494C-492E-44E5-9667-CFD6CC41E83D
P2860
Parameters related to lipid metabolism as markers of myelination in mouse brain.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@ast
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@en
type
label
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@ast
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@en
prefLabel
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@ast
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@en
P2093
P2860
P1476
Parameters related to lipid metabolism as markers of myelination in mouse brain.
@en
P2093
P2860
P356
10.1046/J.1471-4159.2001.00015.X
P407
P577
2001-01-01T00:00:00Z